Drug Profile
NI 205
Alternative Names: NI-205Latest Information Update: 12 May 2021
Price :
$50
*
At a glance
- Originator Neurimmune Therapeutics
- Class Antidementias; Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Amyotrophic lateral sclerosis; Frontotemporal dementia